Dr. Reddy's Laboratories
Dr. Kunal Joshi is an experienced professional in the pharmaceutical and biotechnology sectors, currently serving as the Head of Marketing for Cell & Gene Therapy at Dr. Reddy's Laboratories since February 2024. Previous roles include leading the commercial launch of CAR T-cell therapy at Immuneel Therapeutics and directing innovation at Stempeutics Research, where Dr. Joshi played a pivotal role in launching approved cell & gene therapy products across India and APAC. A proven track record in marketing strategy and digital transformation was established during tenures with AstraZeneca and Johnson & Johnson, where Dr. Joshi received several accolades, including the Business World Healthcare 40 under 40 award and multiple recognitions for innovation and marketing excellence. Dr. Joshi holds an MBA in Marketing & Strategy, a postgraduate degree in Intellectual Property Rights Law, and a medical degree (MBBS).
This person is not in the org chart
This person is not in any offices
Dr. Reddy's Laboratories
68 followers
Dr. Reddy’s Laboratories Ltd. is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy’s operates in markets across the globe. Their major markets include – USA, India, Russia & CIS countries, and Europe.